Notch Signalling in Breast Development and Cancer

被引:58
作者
Edwards, Abigail [1 ]
Brennan, Keith [1 ]
机构
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
关键词
Notch signalling; mammary gland development; breast cancer; cancer hallmarks; breast cancer therapy; MAMMARY-GLAND DEVELOPMENT; INHIBITS TUMOR-GROWTH; EPITHELIAL-MESENCHYMAL TRANSITION; GAMMA-SECRETASE INHIBITORS; ESTROGEN-RECEPTOR-ALPHA; STEM-CELLS; UP-REGULATION; TRANSCRIPTIONAL TARGET; MONOCLONAL-ANTIBODY; THERAPY RESISTANCE;
D O I
10.3389/fcell.2021.692173
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Notch signalling pathway is a highly conserved developmental signalling pathway, with vital roles in determining cell fate during embryonic development and tissue homeostasis. Aberrant Notch signalling has been implicated in many disease pathologies, including cancer. In this review, we will outline the mechanism and regulation of the Notch signalling pathway. We will also outline the role Notch signalling plays in normal mammary gland development and how Notch signalling is implicated in breast cancer tumorigenesis and progression. We will cover how Notch signalling controls several different hallmarks of cancer within epithelial cells with sections focussed on its roles in proliferation, apoptosis, invasion, and metastasis. We will provide evidence for Notch signalling in the breast cancer stem cell phenotype, which also has implications for therapy resistance and disease relapse in breast cancer patients. Finally, we will summarise the developments in therapeutic targeting of Notch signalling, and the pros and cons of this approach for the treatment of breast cancer.
引用
收藏
页数:24
相关论文
共 258 条
  • [1] Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy
    Abravanel, Daniel L.
    Belka, George K.
    Pan, Tien-chi
    Pant, Dhruv K.
    Collins, Meredith A.
    Sterner, Christopher J.
    Chodosh, Lewis A.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (06) : 2484 - 2496
  • [2] A Role for Notch Signalling in Breast Cancer and Endocrine Resistancesssss
    Acar, Ahmet
    Simoes, Bruno M.
    Clarke, Robert B.
    Brennan, Keith
    [J]. STEM CELLS INTERNATIONAL, 2016, 2016
  • [3] Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
    Agrawal, Nishant
    Frederick, Mitchell J.
    Pickering, Curtis R.
    Bettegowda, Chetan
    Chang, Kyle
    Li, Ryan J.
    Fakhry, Carole
    Xie, Tong-Xin
    Zhang, Jiexin
    Wang, Jing
    Zhang, Nianxiang
    El-Naggar, Adel K.
    Jasser, Samar A.
    Weinstein, John N.
    Trevino, Lisa
    Drummond, Jennifer A.
    Muzny, Donna M.
    Wu, Yuanqing
    Wood, Laura D.
    Hruban, Ralph H.
    Westra, William H.
    Koch, Wayne M.
    Califano, Joseph A.
    Gibbs, Richard A.
    Sidransky, David
    Vogelstein, Bert
    Velculescu, Victor E.
    Papadopoulos, Nickolas
    Wheeler, David A.
    Kinzler, Kenneth W.
    Myers, Jeffrey N.
    [J]. SCIENCE, 2011, 333 (6046) : 1154 - 1157
  • [4] Albain K., 2010, 33 ANN CTRC AACR SAN
  • [5] Direct regulation of Gata3 expression determines the T helper differentiation potential of notch
    Amsen, Derk
    Antov, Andrey
    Jankovic, Dragana
    Sher, Alan
    Radtke, Freddy
    Souabni, Abdallah
    Busslinger, Meinrad
    McCright, Brent
    Gridley, Thomas
    Flavell, Richard A.
    [J]. IMMUNITY, 2007, 27 (01) : 89 - 99
  • [6] Therapeutic modulation of Notch signalling - are we there yet?
    Andersson, Emma R.
    Lendahl, Urban
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (05) : 359 - 380
  • [7] Notch signaling: simplicity in design, versatility in function
    Andersson, Emma R.
    Sandberg, Rickard
    Lendahl, Urban
    [J]. DEVELOPMENT, 2011, 138 (17): : 3593 - 3612
  • [8] The Varied Roles of Notch in Cancer
    Aster, Jon C.
    Pear, Warren S.
    Blacklow, Stephen C.
    [J]. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 12, 2017, 12 : 245 - 275
  • [9] Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism
    Ayyanan, A
    Civenni, G
    Ciarloni, L
    Morel, C
    Mueller, N
    Lefort, K
    Mandinova, A
    Raffoul, W
    Fiche, M
    Dotto, GP
    Brisken, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (10) : 3799 - 3804
  • [10] A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors
    Azaro, Analia
    Massard, Christophe
    Tap, William D.
    Cassier, Philippe A.
    Merchan, Jaime
    Italiano, Antoine
    Anderson, Bailey
    Yuen, Eunice
    Yu, Danni
    Oakley, Gerard, III
    Benhadji, Karim A.
    Pant, Shubham
    [J]. INVESTIGATIONAL NEW DRUGS, 2021, 39 (04) : 1089 - 1098